Cohance Lifesciences receives 4 FDA Form 483 observations after plant inspection 7 mins ago
Cohance Lifesciences completed a USFDA inspection at its plant. The company received four observations on FDA Form 483 following the inspection. Cohance Lifesciences plans to initiate corrective measures and respond promptly to the observations.